Samsung SDS Co Ltd
KRX:018260
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
132 000
171 500
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Samsung SDS Co Ltd
Current Assets | 8.2T |
Cash & Short-Term Investments | 5.5T |
Receivables | 2.2T |
Other Current Assets | 440.4B |
Non-Current Assets | 4.2T |
Long-Term Investments | 179.6B |
PP&E | 2.5T |
Intangibles | 818.9B |
Other Non-Current Assets | 686.2B |
Current Liabilities | 2.4T |
Accounts Payable | 692.6B |
Accrued Liabilities | 804.6B |
Other Current Liabilities | 894.6B |
Non-Current Liabilities | 1.3T |
Long-Term Debt | 656.5B |
Other Non-Current Liabilities | 614.6B |
Balance Sheet
Samsung SDS Co Ltd
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
816 693
|
856 805
|
1 190 227
|
931 461
|
1 161 684
|
1 148 184
|
1 199 286
|
1 080 888
|
1 392 134
|
1 787 695
|
|
Cash |
816 693
|
856 805
|
1 190 227
|
931 461
|
1 161 684
|
1 148 184
|
1 199 286
|
1 080 888
|
1 392 134
|
1 787 695
|
|
Short-Term Investments |
833 890
|
1 093 896
|
1 265 543
|
1 993 753
|
2 510 208
|
2 682 467
|
2 995 006
|
3 510 296
|
3 634 760
|
3 703 327
|
|
Total Receivables |
1 351 866
|
1 703 755
|
1 874 303
|
1 961 977
|
1 997 497
|
2 233 413
|
2 125 472
|
2 608 781
|
2 550 739
|
2 228 883
|
|
Accounts Receivables |
883 605
|
935 603
|
1 046 092
|
1 209 630
|
1 291 752
|
1 439 462
|
1 500 926
|
1 918 856
|
1 651 519
|
1 482 448
|
|
Other Receivables |
468 261
|
768 152
|
828 211
|
752 347
|
705 745
|
793 951
|
624 546
|
689 925
|
899 220
|
746 435
|
|
Inventory |
35 713
|
16 742
|
16 226
|
24 760
|
18 774
|
17 482
|
25 747
|
44 302
|
40 898
|
23 535
|
|
Other Current Assets |
189 912
|
174 093
|
202 148
|
205 548
|
193 612
|
302 302
|
235 642
|
331 701
|
387 233
|
416 861
|
|
Total Current Assets |
3 228 074
|
3 845 289
|
4 548 448
|
5 117 499
|
5 881 776
|
6 383 847
|
6 581 153
|
7 575 968
|
8 005 764
|
8 160 300
|
|
PP&E Net |
1 137 681
|
1 228 944
|
1 051 961
|
1 028 558
|
1 068 726
|
1 539 236
|
1 462 784
|
1 618 532
|
2 348 032
|
2 476 137
|
|
PP&E Gross |
1 137 681
|
1 228 944
|
1 051 961
|
1 028 558
|
1 068 726
|
1 539 236
|
1 462 784
|
1 618 532
|
2 348 032
|
2 476 137
|
|
Accumulated Depreciation |
1 374 641
|
1 524 695
|
1 482 202
|
1 381 103
|
1 456 095
|
1 557 754
|
1 693 076
|
1 773 955
|
1 984 241
|
2 308 099
|
|
Intangible Assets |
463 456
|
511 169
|
449 445
|
344 354
|
254 272
|
199 612
|
167 326
|
145 612
|
151 537
|
161 532
|
|
Goodwill |
546 417
|
589 393
|
591 943
|
590 505
|
590 697
|
590 105
|
569 399
|
569 750
|
561 211
|
657 322
|
|
Long-Term Investments |
45 576
|
41 192
|
48 431
|
53 192
|
70 571
|
131 747
|
122 770
|
182 052
|
152 789
|
179 574
|
|
Other Long-Term Assets |
124 840
|
115 691
|
151 777
|
143 653
|
147 807
|
176 689
|
251 486
|
425 518
|
733 091
|
686 160
|
|
Other Assets |
546 417
|
589 393
|
591 943
|
590 505
|
590 697
|
590 105
|
569 399
|
569 750
|
561 211
|
657 322
|
|
Total Assets |
5 546 045
N/A
|
6 331 679
+14%
|
6 842 004
+8%
|
7 277 761
+6%
|
8 013 849
+10%
|
9 021 236
+13%
|
9 154 919
+1%
|
10 517 432
+15%
|
11 952 425
+14%
|
12 321 025
+3%
|
|
Liabilities | |||||||||||
Accounts Payable |
361 941
|
392 543
|
389 603
|
443 248
|
553 321
|
544 465
|
574 354
|
821 773
|
676 243
|
692 638
|
|
Accrued Liabilities |
333 820
|
364 183
|
462 286
|
423 285
|
530 638
|
572 166
|
541 236
|
815 329
|
1 028 882
|
804 588
|
|
Short-Term Debt |
4 288
|
2 573
|
2 608
|
820
|
775
|
798
|
900
|
464
|
0
|
0
|
|
Current Portion of Long-Term Debt |
8 142
|
5 885
|
2 464
|
10
|
0
|
149 950
|
125 988
|
149 014
|
192 818
|
211 305
|
|
Other Current Liabilities |
409 778
|
624 730
|
490 424
|
457 500
|
490 063
|
430 809
|
478 280
|
583 709
|
595 379
|
683 331
|
|
Total Current Liabilities |
1 117 969
|
1 389 915
|
1 347 385
|
1 324 863
|
1 574 796
|
1 698 187
|
1 720 757
|
2 370 290
|
2 493 323
|
2 391 861
|
|
Long-Term Debt |
7 810
|
2 294
|
1 625
|
0
|
10
|
295 735
|
238 796
|
312 583
|
676 179
|
656 519
|
|
Deferred Income Tax |
137 393
|
112 799
|
144 865
|
164 663
|
175 950
|
176 910
|
239 267
|
274 204
|
199 571
|
185 755
|
|
Minority Interest |
101 765
|
188 091
|
150 430
|
161 151
|
166 097
|
179 362
|
190 081
|
214 980
|
243 777
|
317 562
|
|
Other Liabilities |
68 848
|
49 819
|
57 004
|
68 806
|
114 541
|
125 246
|
96 991
|
116 654
|
116 382
|
111 318
|
|
Total Liabilities |
1 433 786
N/A
|
1 742 918
+22%
|
1 701 309
-2%
|
1 719 482
+1%
|
2 031 394
+18%
|
2 475 441
+22%
|
2 485 892
+0%
|
3 288 712
+32%
|
3 729 232
+13%
|
3 663 015
-2%
|
|
Equity | |||||||||||
Common Stock |
38 689
|
38 689
|
38 689
|
38 689
|
38 689
|
38 689
|
38 689
|
38 689
|
38 689
|
38 689
|
|
Retained Earnings |
3 050 103
|
3 449 529
|
3 874 713
|
4 347 048
|
4 821 747
|
5 403 504
|
5 661 319
|
6 086 849
|
7 000 953
|
7 446 855
|
|
Additional Paid In Capital |
1 297 467
|
1 297 467
|
1 297 467
|
1 297 467
|
1 297 467
|
1 297 467
|
1 297 467
|
1 297 467
|
1 297 467
|
1 297 467
|
|
Unrealized Security Profit/Loss |
6 047
|
2 209
|
2 299
|
1 729
|
9 757
|
7 575
|
11 564
|
52 176
|
48 913
|
51 814
|
|
Treasury Stock |
1 592
|
1 593
|
1 593
|
1 593
|
1 593
|
1 593
|
1 593
|
1 593
|
1 593
|
1 593
|
|
Other Equity |
278 454
|
197 540
|
70 881
|
125 062
|
183 612
|
199 847
|
338 418
|
244 867
|
161 236
|
175 222
|
|
Total Equity |
4 112 259
N/A
|
4 588 761
+12%
|
5 140 695
+12%
|
5 558 279
+8%
|
5 982 455
+8%
|
6 545 795
+9%
|
6 669 027
+2%
|
7 228 721
+8%
|
8 223 193
+14%
|
8 658 009
+5%
|
|
Total Liabilities & Equity |
5 546 045
N/A
|
6 331 679
+14%
|
6 842 004
+8%
|
7 277 761
+6%
|
8 013 849
+10%
|
9 021 236
+13%
|
9 154 919
+1%
|
10 517 432
+15%
|
11 952 425
+14%
|
12 321 025
+3%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
77
|
77
|
77
|
77
|
77
|
77
|
77
|
77
|
77
|
77
|